
Clarification18 Sept 2026, 05:40 pm
Novartis India Ltd Issues Corrigendum for 78th AGM Notice
AI Summary
Novartis India Limited has issued a corrigendum to its 78th Annual General Meeting (AGM) notice dated August 27, 2026. The corrigendum addresses two inadvertent omissions: first, missing details in the explanatory statement for Agenda Item No. 9 concerning the Employee Stock Option Scheme 2026 (ESOP 2026), as required by SEBI regulations. Second, the nature of the company's industry was omitted from Annexure 2 pertaining to Agenda Item No. 8, and it has been clarified as "Pharmaceutical Industry". The company emphasizes that all other contents of the original AGM notice remain unchanged and the corrigendum forms an integral part of the notice.
Key Highlights
- Corrigendum issued for Novartis India's 78th AGM notice.
- Omissions related to ESOP 2026 details and industry nature corrected.
- Details for ESOP 2026 were omitted from the explanatory statement.
- Company's industry clarified as 'Pharmaceutical Industry'.
- All other AGM notice contents remain unchanged.
Price Impact
More from NOVARTIND